Soleno Therapeutics (SLNO) Change in Cash (2016 - 2019)
Historic Change in Cash for Soleno Therapeutics (SLNO) over the last 7 years, with Q4 2019 value amounting to $9.5 million.
- Soleno Therapeutics' Change in Cash fell 2327.31% to $9.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$2.4 million, marking a year-over-year decrease of 13967.14%. This contributed to the annual value of -$81.8 million for FY2024, which is 15271.7% down from last year.
- According to the latest figures from Q4 2019, Soleno Therapeutics' Change in Cash is $9.5 million, which was down 2327.31% from -$4.3 million recorded in Q3 2019.
- Over the past 5 years, Soleno Therapeutics' Change in Cash peaked at $12.4 million during Q4 2018, and registered a low of -$4.3 million during Q3 2019.
- In the last 5 years, Soleno Therapeutics' Change in Cash had a median value of -$2.0 million in 2015 and averaged $637064.3.
- Its Change in Cash has fluctuated over the past 5 years, first tumbled by 55022.52% in 2015, then soared by 68365.1% in 2017.
- Over the past 5 years, Soleno Therapeutics' Change in Cash (Quarter) stood at $774813.0 in 2015, then tumbled by 446.99% to -$2.7 million in 2016, then surged by 526.0% to $11.5 million in 2017, then increased by 8.2% to $12.4 million in 2018, then fell by 23.27% to $9.5 million in 2019.
- Its last three reported values are $9.5 million in Q4 2019, -$4.3 million for Q3 2019, and -$3.9 million during Q2 2019.